TOG Review (RCOG Journal)
MRCOG Part 2
Gynaecological Problems
Investigation and management of postcoital bleeding
Key Statistics
- 0.7–9.0% — Community prevalence of PCB
- 1:2400 — Cervical cancer risk, PCB age 45–54
- 50% — PCB with no identifiable cause
Don't-miss facts
-
PCB PPV for cervical cancer is low: 1:44,000 (age 20–24) vs 1:2400 (age 45–54) – but excluding cervical cancer is still the principal aim
-
Suspicious cervix on exam → refer directly to colposcopy within 2 weeks; do NOT take a screening smear in a suspicious cervix
-
Ask HARK questions (Humiliation, Afraid, Rape, Kick) – all PCB patients screened for domestic/sexual abuse
-
Chlamydia: azithromycin 1 g stat + 500 mg OD ×2 days or doxycycline 100 mg BD ×7 days. Gonorrhoea: ceftriaxone 1 g IM stat + mandatory test of cure
-
Cervical polyps: symptomatic/atypical cytology → avulse + histology (silver nitrate haemostasis); postmenopausal women – up to 55% also have endometrial pathology – add hysteroscopy/sampling
-
CIN1 → re-screen at 12 months; CIN2/3 → see-and-treat excision (2× relative ↑ preterm birth risk, absolute risk low)
-
Lichen sclerosus – 4.0–6.7% vulval SCC risk – annual review
-
A previous negative screening test does NOT exclude cervical cancer – never let it delay colposcopy referral if clinically suspicious
Key drug regimens at a glance
Chlamydia: azithromycin 1g stat+500mg OD×2d / doxycycline 100mg BD×7d Gonorrhoea: ceftriaxone 1g IM stat + test of cure
PID outpatient: IM ceftriaxone 1g + doxycycline 100mg BD + metronidazole 400mg BD ×14d
Abbreviation Key
- PCB — postcoital bleeding
- PID — pelvic inflammatory disease
- IMB — intermenstrual bleeding
- BASHH — British Association for Sexual Health and HIV
- CIN — cervical intraepithelial neoplasia
- GUM — genitourinary medicine
- VIN — vulval intraepithelial neoplasia
- USS — ultrasound scan
- VAIN — vaginal intraepithelial neoplasia
- IUCD — intrauterine contraceptive device
- hrHPV — high-risk human papillomavirus
- DHEA — dehydroepiandrosterone
- NAAT — nucleic acid amplification test
- FGM — female genital mutilation
- STI — sexually transmitted infection
- HRT — hormone replacement therapy
Source: Owens GL et al. Investigation and management of postcoital bleeding. The Obstetrician & Gynaecologist 2022;24:24–30. doi:10.1111/tog.12780
MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).